Press release
Primary Ciliary Dyskinesia Market to Witness an Outstanding Growth of 6.7% by 2023
Primary Ciliary Dyskinesia Market Information: By Diagnosis (Genetic Testing, Electron Microscopy), By Treatment, and By End User - Global Forecast till 2023Market Research Future adds new report of “Primary Ciliary Dyskinesia Market Research Report - Global Forecast till 2023” it contains Company information, geographical data and Table of Content
Primary ciliary dyskinesia (PCD), also kown as immotile ciliary syndrome or Kartagener syndrome. Primary ciliary dyskinesia is a rare disorder and is a type of chronic respiratory tract infections, normally occurs in internal organs of human body. The major symptoms of this condition are caused by abnormal cilia and flagella. Normally cilia are microscopic, finger-like projections that stick out from the surface of cells. They are found in the linings of the airway, the reproductive system, and other organs and tissues. Flagella are tail-like structures, similar to cilia that propel sperm cells forward.
In some cases, mutations in the genes can cause primary ciliary dyskinesia result in defective cilia that move abnormally or are unable to move. As cilia have many important functions within the body, defects in these cell structures cause diseased condition
Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/4419
Competitive Analysis:
Some of the key players in this market are AstraZeneca, Boehringer Ingelheim GmbH, GlaxoSmithKline, Novartis AG, Pfizer Inc., Teva UK Limited, Masimo Corporation (U.S.), BD (U.S.), Portex Division of Smith Industries Medical System, Teruma Medical Corporation, HTL STREFA SA, Greinier Bio One International GmBH., F. Hoffman La Roche AG, Bayer AG., Acare Technology Co., Medline Industries Inc., Ltd., Hill-Rom Holdings Inc., Allied Healthcare Inc., Rotech Healthcare Inc., and others.
Market Highlight:
Increasing prevalence of respiratory tract diseases is one of the major factors for the growth of the market during the forecast period. According to the Centers for Disease Control and Prevention (2014), 9.3 million adults diagnosed with respiratory problems. Whereas, 147,101 deaths occurred due to chronic lower respiratory diseases.It is predicted to be the 3rd most death causing factor.
According to the World Health Organization (WHO), over 7 million deaths occur each year of which more than 6 million deaths result from direct use of tobacco. Moreover, According to Eurostat’s, (2014), COPD (Chronic Obstructive Pulmonary Disease) affected more than 200 million people worldwide and is one of the major diseases whose prevalence is increasing across the globe.
However, high cost of the current treatment methods and lack of awareness about rare respiratory diseases such as primary ciliary dyskinesia may hamper the market growth over the review period.
The global primary ciliary dyskinesia market is expected to grow at a CAGR of ~6.7% during the forecast period 2017-2023.
Market Segmentation:
The global primary ciliary dyskinesia market is segmented on the basis of diagnosis, treatment, and end user. On the basis of diagnosis, the market is segmented into genetic testing, electron microscopy, and others. On the basis of treatment, the market is categorized into drug treatment, radiotherapy, chemotherapy, others. On the basis of drug treatment, it is further segmented into clarithromycin, erythromycin and azithromycin, and others. On the basis of end user, the market is segmented into hospitals & clinics, research centers, and others.
Browse Report Details @ https://www.marketresearchfuture.com/reports/primary-ciliary-dyskinesia-market-4419
Regional Analysis
The Americas dominates the global primary ciliary dyskinesia market owing to the presence of strong economic condition, huge development in healthcare domain, and focus of research institutions on updating technology for rare diseases diagnosis and treatment methods. Moreover, advanced hospitals infrastructures, availability of skilled healthcare professional are boosting the growth of the market.
Europe holds the second largest primary ciliary dyskinesia market across the globe due to encouraging government policies for research & development and healthcare professionals by various European countries such as France and Germany. Moreover, according to Eurostat’s, (2014), over 401000 deaths were caused by respiratory system diseases, which are equivalent to 8.0 % of all deaths. Proportion of deaths in the UK from respiratory diseases is considerably higher than the other European countries, which will drive the market growth in this region during the forecast period.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Ciliary Dyskinesia Market to Witness an Outstanding Growth of 6.7% by 2023 here
News-ID: 791290 • Views: …
More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…

Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…

Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…

Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for Primary
Premier Primary Care Medicine Recognized as Top-Rated Primary Care Physician in …
Premier Primary Care Medicine has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible, high-quality primary care, same-day and next-day appointments, and an approach centered on long-term patient relationships.
Marietta, GA - September 16, 2025 - Premier Primary Care Medicine [https://www.premierpcmed.com/] has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible,…
Direct Primary Care Market
Direct Primary Care Market Worth 80.4 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Direct Primary Care Market"- By Type (Clinical Services, Telehealth Services, Laboratory Services, Consultative Services), Care Setting (Office-Based DPC Practices, Home-Based DPC Practices, Telehealth-Only DPC Practices, Hybrid DPC Practices), End Users (Individuals, Employers, Small Businesses, Large Corporations, Insurance Companies (offering DPC as…
Primary Sclerosing Cholangitis Market
Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to liver damage and, ultimately, liver failure. The disease progresses slowly and often goes unnoticed in its early stages. Although the exact cause of PSC remains unknown, it is commonly associated with other inflammatory bowel diseases, particularly ulcerative colitis. The management of PSC includes symptom control, slowing disease progression, and…
Primary Healthcare Conference 2023
3rd World Congress on Primary Healthcare and Medicare Summit
Mercure Roma West, Viale degli Eroi di Cefalonia, 301, 00128 Rome, Italy
Email primaryhealthcare@pulsusgathering.org
On behalf of the Conference Organizing Committee, we would like to invite all of you for the "3rd Word Congress on Primary Healthcare and Medicare", which is going to be held in Rome, Italy on September 21-23, 2023. Primary Healthcare 2023 focuses on the basic theme "To Manifest the Multimorbidity…
Primary Lithium Battery (Primary Lithium Batteries) Market Key Companies and Ana …
The global lithium primary batteries market size will grow from $2.83 billion in 2022 to $2.9 billion in 2023 at a compound annual growth rate (CAGR) of 2.5%
Global " Primary Lithium Battery (Primary Lithium Batteries) Market" 2022 Reports give a Key study on the industry status of the Primary Lithium Battery (Primary Lithium Batteries) Manufacturer with the specific statistics, meaning, definition, SWOT Analysis, expert opinion, and recent development across…
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include:
1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk…